These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8101069)

  • 21. Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine.
    Dearden CE; Matutes E; Hilditch BL; Swansbury GJ; Catovsky D
    Br J Haematol; 1999 Aug; 106(2):515-9. PubMed ID: 10460614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
    Piro LD; Carrera CJ; Carson DA; Beutler E
    N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study.
    von Rohr A; Schmitz SF; Tichelli A; Hess U; Piguet D; Wernli M; Frickhofen N; Konwalinka G; Zulian G; Ghielmini M; Rufener B; Racine C; Fey MF; Cerny T; Betticher D; Tobler A;
    Ann Oncol; 2002 Oct; 13(10):1641-9. PubMed ID: 12377655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of action of pentostatin and cladribine in hairy cell leukemia.
    Johnston JB
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():43-5. PubMed ID: 21463108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).
    Estey EH; Kurzrock R; Kantarjian HM; O'Brien SM; McCredie KB; Beran M; Koller C; Keating MJ; Hirsch-Ginsberg C; Huh YO
    Blood; 1992 Feb; 79(4):882-7. PubMed ID: 1346577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in therapy for hairy cell leukemia. A review.
    Jaiyesimi IA; Kantarjian HM; Estey EH
    Cancer; 1993 Jul; 72(1):5-16. PubMed ID: 7685243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine.
    Seymour JF; Estey EH; Keating MJ; Kurzrock R
    Leukemia; 1995 May; 9(5):929-32. PubMed ID: 7769859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hairy cell leukemia.
    Savoie L; Johnston JB
    Curr Treat Options Oncol; 2001 Jun; 2(3):217-24. PubMed ID: 12057121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Durable complete remissions after 2'-deoxycoformycin treatment in patients with hairy cell leukemia resistant to interferon alpha.
    Blick M; Lepe-Zuniga JL; Doig R; Quesada JR
    Am J Hematol; 1990 Mar; 33(3):205-9. PubMed ID: 2301379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA).
    Jehn U; Gawaz M; Grunewald R; Hill W; Lorenz B; Stôtzer O
    Anticancer Res; 1993; 13(5C):1809-14. PubMed ID: 7903521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hairy cell leukaemia, its therapy and prognosis (historical review with own experiences).
    Chrobák L; Podzimek K; Zak P; Plísková L; Voglová J
    Acta Haematol Pol; 1995; 26(2 Suppl 1):56-62. PubMed ID: 7653236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deoxycoformycin induces long-lasting remissions in hairy cell leukemia: clinical and biological results of two different regimens.
    Annino L; Ferrari A; Giona F; Cimino G; Crescenzi S; Cava MC; Pacchiarotti A; Mandelli F
    Leuk Lymphoma; 1994; 14 Suppl 1():115-9. PubMed ID: 7820042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete hematologic remissions in chronic-phase, Philadelphia-chromosome-positive, chronic myelogenous leukemia after 2-chlorodeoxyadenosine.
    Saven A; Piro LD; Lemon RH; Figueroa ML; Kosty M; Ellison DJ; Beutler E
    Cancer; 1994 Jun; 73(12):2953-63. PubMed ID: 7911068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.
    Goodman GR; Burian C; Koziol JA; Saven A
    J Clin Oncol; 2003 Mar; 21(5):891-6. PubMed ID: 12610190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.
    Zinzani PL; Magagnoli M; Bendandi M; Tani M; Stefoni V; Cellini C; Poggi S; Piccioli M; Pileri S; Tura S
    Haematologica; 2000 Sep; 85(9):922-5. PubMed ID: 10980629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pentostatin induces durable remissions in hairy cell leukemia.
    Cassileth PA; Cheuvart B; Spiers AS; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
    J Clin Oncol; 1991 Feb; 9(2):243-6. PubMed ID: 1988572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2-chlorodeoxyadenosine therapy.
    Gillis S; Amir G; Bennett M; Polliack A
    Eur J Haematol; 2001 Jan; 66(1):7-10. PubMed ID: 11168501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The optimal management of hairy cell leukaemia.
    Gollard R; Lee TC; Piro LD; Saven A
    Drugs; 1995 Jun; 49(6):921-31. PubMed ID: 7543840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Lauria F; Benfenati D; Raspadori D; Rondelli D; Zinzani PL; Tura S
    Leuk Lymphoma; 1993 Nov; 11(5-6):399-404. PubMed ID: 7907247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Subcutaneous therapy of hairy cell leukemia with 2-chlorodeoxyadenosine].
    Nielsen OJ; Hippe E; Priø TK; Juliusson G
    Ugeskr Laeger; 1994 Apr; 156(16):2407-9. PubMed ID: 7912015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.